The Alicante startup Ozeanic continues to push its growth goals with an innovative portable electronic device that purifies water. The system is described as the first and only bottle in the world capable of purifying water with ozone. This bottle ensures potable and sustainable water wherever needed, removing 99.99% of viruses, bacteria, and other pathogens, while also neutralizing chlorine.
Led and founded by Jose Ramon Campos, the company has secured a patent for its device in the United States. This achievement supports the international expansion strategy, with plans to select markets such as Spain, France, Italy, and now the United States for commercialization. This patent adds to a previous one granted in Spain. [Attribution: Ozeanic press release]
Campos emphasizes that the device is more than just a technological step forward. It holds the potential to make a meaningful impact in communities worldwide that suffer from infectious diseases due to limited access to safe drinking water, an increasingly scarce and costly resource. He notes that his long-term hope is for this invention to reach many people and contribute in a small way to solving the global challenge of drinking-water availability. [Attribution: Interview with Campos]
From Ozeanic’s perspective, more than 80 percent of infectious diseases are transmitted through water, underscoring the urgent need for safe hydration solutions in many regions. [Attribution: Ozeanic data]
The Atlantic Leap
Regarding the new milestone, Campos notes that after a successful introduction of Ozeanic in the Spanish market, efforts are underway to refine the device, strengthen the brand, and work on a detailed plan to bring the product to the USA. The United States market offers compelling advantages for introducing and developing new technology products. Access to a population of 341 million people, a language common to most users, and a GDP per capita well above the European average create attractive strategic conditions. The culture of American innovation and entrepreneurship provides a favorable environment for launching new products and technologies. Readily available funding in the United States, driven by a higher concentration of investors interested in emerging technologies, is vital for projects requiring early-stage investment. The country’s demographic diversity also enables comprehensive market testing across a broad range of niches. [Attribution: Campos interview]
The company, founded in 2021 with a share capital of 105,000 euros, plans to close a seed round of 200,000 euros in 2024. Funds are earmarked mainly for marketing in Spain and product development. Once the USA patent is published, the plan is to enter that market in 2025, a trajectory that recognizes immense potential but also strong competition and the need for new investment. Since its launch, the firm has established a presence in five European markets. [Attribution: Company overview]